anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Resolution

Beat collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 42,534
Current window 30,841-30,870
Pages 1,418
Rows per page 30
Beat: Resolutionclear collectionreset all
18 30 60

Beat

30,841-30,870 of 42,534

filter-aware
10
The slide uses a visual representation of an antibody molecule with callouts to specific engineering improvements, supported by a scatter plot showing clinical precedent for half-life extension.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Aha Moment1 hit
11
Uses a visual metaphor of antibody combination to explain the therapeutic strategy.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Aha Moment1 hit
12
The slide uses a Venn diagram to represent the intersection of genetic targets and a bar chart to demonstrate the efficacy of patient selection.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Aha Moment1 hit
13
The slide uses a Gantt-style pipeline visualization to show progress of seven distinct programs.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Aha Moment1 hit
14
The slide uses a Gantt-style layout to show progress across Discovery, IND-Enabling, and Clinical stages.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Aha Moment1 hit
15
Includes a KOL quote and two charts: a bar chart for global sales and a line chart for market share.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Aha Moment1 hit
16
The chart uses a vertical axis to imply a safety spectrum (Safest to Riskiest) and a horizontal axis for efficacy (clinical remission %).Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Aha Moment1 hit
39
Includes Credit Suisse AG's issuance following the convenience date of consolidation 31.5.23; The nominal amount outstanding has been reduced compared to the nominal amount at issue date as a result of a tender offer launched by UBS Group AG on 22.3.23UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
40
The table lists 11 specific financial instruments with their ISIN, type, currency, notional value, coupon rate, and maturity date.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
41
The slide uses a grid-based layout to categorize liquidity management into regulatory, governance, stress testing, and contingency planning pillars.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
42
UBS | Fixed Income Presentation Deck | 44 slidesUBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
43
UBS | Fixed Income Presentation Deck | 44 slidesUBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
44
UBS | Fixed Income Presentation Deck | 44 slidesUBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
17
UBS | Results Presentation Deck | 41 slidesUBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Before After1 hit
18
The chart illustrates the bridge from Profit before tax to adjusted Profit before tax by accounting for negative goodwill and integration costs.UBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Before After1 hit
19
Two waterfall charts showing the derivation of negative goodwill and the components of PPA adjustments.UBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Before After1 hit
20
UBS | Results Presentation Deck | 41 slidesUBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Before After1 hit
21
The slide compares absolute values (bn) with percentage ratios (RWA and LRD) to demonstrate capital strength.UBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
22
The chart shows the reduction of drawn SNB liquidity facilities over time, highlighting the repayment of higher-cost facilities.UBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
23
The chart uses a waterfall structure to bridge individual business unit performance to a total figure, then adjusts for integration-related expenses.UBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
24
Excludes Credit Suisse; includes footnote regarding seasonal tax payments.UBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Maturity Curve1 hit
25
Excludes Credit Suisse; includes YoY and QoQ growth metrics.UBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Maturity Curve1 hit
26
Excludes Credit Suisse; includes specific footnotes regarding gains on sale.UBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Maturity Curve1 hit
11
Yatsen | Results Presentation Deck | 17 slidesYatsen | Results Presentation Deck | 17 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Action1 hit
12
Yatsen | Results Presentation Deck | 17 slidesYatsen | Results Presentation Deck | 17 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Action1 hit
13
The slide explains the drivers behind the financial performance metrics.Yatsen | Results Presentation Deck | 17 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Action1 hit
14
The chart shows a breakdown of R&D, G&A, S&M, and Fulfillment expenses.Yatsen | Results Presentation Deck | 17 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Action1 hit
15
The slide provides a detailed breakdown of adjustments made to GAAP net income to arrive at non-GAAP figures, including share-based compensation, amortization, and investment revaluations.Yatsen | Results Presentation Deck | 17 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Action1 hit
16
The chart displays two distinct metrics: a running balance (top row) and quarterly cashflow (bars).Yatsen | Results Presentation Deck | 17 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Action1 hit
17
Yatsen | Results Presentation Deck | 17 slidesYatsen | Results Presentation Deck | 17 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Action1 hit